Category Archives: Food Safety News

Update on findings in the FDA cold storage area on the NIH campus

As previously reported, on July 1, 2014, biological samples were found in the cold storage area of U.S. Food and Drug Administration laboratories on the National Institutes of Health campus. The FDA has since acquired additional information from the federal investigative agencies regarding inventories of the materials.

United States enters consent decree with New York dietary supplement manufacturer

Triceutical, Inc., of Farmingdale, New York, and Liqun Zhang, the company’s president, have agreed to stop production and distribution of dietary supplements under the terms of a consent decree because of violations of federal dietary supplement regulations, known as Current Good Manufacturing Practice (cGMP) requirements.

FDA seeks permanent injunction against California pharmaceutical company

On June 25, the U.S. Department of Justice, at the request of the U.S. Food and Drug Administration, filed a complaint for permanent injunction in the U.S. District Court for the Central District of California against Laclede, Inc. (Laclede) of Rancho Dominguez, California, and its president, Michael A. Pellico. The complaint claims that Laclede illegally distributes over-the-counter vaginal drug products without required FDA approval.

Flowers Foods Issues Allergy Alert and Voluntary Recall on Limited Quantity of Sunbeam, Bunny, Flowers Deli, and Ingles Bar-B-Q Bread Sold in Alabama, Georgia, Louisiana, and Tennessee

Flowers Foods (NYSE: FLO) is voluntarily recalling the following brands of Bar-B-Q bread because they may contain undeclared milk. People who have allergies to dairy products run the risk of serious or life-threatening allergic reaction if they consume these products. No illnesses have been reported to date.
Read The Complete Story!

FDA outlines expectations for human drug compounders, including registered outsourcing facilities

Today, the U.S. Food and Drug Administration issued several policy documents regarding compounded drug products for human use, as part of the agency’s continuing effort to implement the compounding provisions of the Drug Quality and Security Act (DQSA), enacted in November 2013. The policy documents consist of a draft interim guidance, a proposed rule, a final guidance, and two revised requests for nominations for the bulk drug substances lists.

FDA allows marketing of first wearable, motorized device that helps people with certain spinal cord injuries to walk

The U.S. Food and Drug Administration today allowed marketing of the first motorized device intended to act as an exoskeleton for people with lower body paralysis (paraplegia) due to a spinal cord injury. ReWalk is a motorized device worn over the legs and part of the upper body that helps an individual sit, stand, and walk with assistance from a trained companion, such as a spouse or home health aide.